Pharmonix Biologicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.00 Cr
as on 15-11-2024
- Revenue -48.27%
(FY 2023)
- Profit -55.49%
(FY 2023)
- Ebitda -58.95%
(FY 2023)
- Net Worth 17.16%
(FY 2023)
- Total Assets 3.09%
(FY 2023)
About Pharmonix Biologicals
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sharad Agarwal, Payal Agarwal, and Sunita serve as directors at the Company.
- CIN/LLPIN
U74999PN2018PTC175443
- Company No.
175443
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Pharmonix Biologicals Private Limited offer?
Pharmonix Biologicals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutraceuticals, Cosmetics, Hair & Beauty Products, Cosmetic Raw Material, Pharma Ingredients & Raw Materials, Pharmaceutical Excipients.
Who are the key members and board of directors at Pharmonix Biologicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharad Agarwal  | Director | 16-Mar-2018 | Current |
| Payal Agarwal | Director | 16-Mar-2018 | Current |
| Sunita | Director | 10-Aug-2024 | Current |
Financial Performance of Pharmonix Biologicals.
Pharmonix Biologicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 48.27% decrease. The company also saw a substantial fall in profitability, with a 55.49% decrease in profit. The company's net worth Soared by an impressive increase of 17.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmonix Biologicals?
In 2023, Pharmonix Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chemster Ingredients Private LimitedActive 6 years 10 monthsSharad Agarwal and Payal Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 04 Jan 2020 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Pharmonix Biologicals?
Pharmonix Biologicals has a workforce of 20 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmonix Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmonix Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
